Edge Therapeutics, Inc. (29) | Human Resources (12)
Browse by Subcategory
Recent Contracts
-
Amended and Restated Executive Employment Agreement by and between Frank K. Bedu-Addo and PDS Biotechnology Corporation, effective as of March 14, 2022
(Filed With SEC on March 31, 2022)
-
PDS Biotechnology Corporation Change of Control Severance Plan effective as of March 14, 2022
(Filed With SEC on March 31, 2022)
-
Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan
(Filed With SEC on December 9, 2020)
-
Consulting Agreement (Michael King)
(Filed With SEC on June 24, 2020)
-
Executive Employment Agreement by and between Gregory Conn, Ph.D. and PDS Biotechnology Corporation, effective as of March 14, 2022
(Filed With SEC on March 31, 2022)
-
Executive Employment Agreement by and between Matthew Hill and PDS Biotechnology Corporation, effective as of March 14, 2022
(Filed With SEC on March 31, 2022)
-
Executive Employment Agreement by and between Lauren V. Wood, M.D. and PDS Biotechnology Corporation, effective as of March 14, 2022
(Filed With SEC on March 31, 2022)
-
Executive Employment Agreement by and between PDS Biotechnology Corporation and Matthew Hill, dated as of October 4, 2021
(Filed With SEC on October 6, 2021)
-
Amendment to Employment Agreement by and between PDS Biotechnology Corporation and Gregory Conn, Ph.D., effective as of June 17, 2021
(Filed With SEC on June 21, 2021)
-
Executive Employment Agreement by and between the Company and Seth L. Van Voorhees, Ph.D
(Filed With SEC on December 9, 2020)
-
Form of Employee Stock Option Agreement under the Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan
(Filed With SEC on December 9, 2020)
-
Employment Agreement, effective June 1, 2019, by and between PDS Biotechnology Corporation and Gregory Conn
(Filed With SEC on August 1, 2019)